John G Ullman & Associates Inc
Source: SEC Form 13F · as of Mar 2026John G Ullman & Associates Inc holds 17 biotech & pharma companies tracked by BioSniper, totaling $54.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$54.2M
| Company | Shares | Value |
|---|---|---|
| MRKMerck & Co., Inc. | 94,272 | $11.3M |
| BMYBRISTOL MYERS SQUIBB CO | 144,565 | $8.8M |
| JAZZJazz Pharmaceuticals plc | 32,833 | $6.2M |
| PFEPFIZER INC | 214,087 | $6.0M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 72,610 | $4.0M |
| UTHRUNITED THERAPEUTICS Corp | 6,355 | $3.8M |
| GEHCGE HealthCare Technologies Inc. | 45,210 | $3.2M |
| ABTABBOTT LABORATORIES | 28,963 | $3.0M |
| LLYELI LILLY & Co | 2,002 | $1.8M |
| ZBHZimmer Biomet Holdings Inc. | 18,866 | $1.7M |
| MRNAModerna, Inc. | 19,550 | $993K |
| GILDGILEAD SCIENCES, INC. | 6,995 | $975K |
| AMGNAMGEN INC | 2,125 | $748K |
| REGNREGENERON PHARMACEUTICALS, INC. | 910 | $703K |
| DGXQuest Diagnostics Incorporated | 2,032 | $398K |
| BAXBaxter International Inc. | 17,793 | $299K |
| ABBVAbbVie Inc. | 1,078 | $234K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.